EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Angiosome-targeted vs non-targeted endovascular revascularization in diabetic foot ischemia: A retrospective cohort study

Sohaib Zoghoul, Mohammad Obeidat, Elhassan Abdallah, Abdullah Al-Hashemi, Rana Shalaby, Israa Al-Hashimi, Ayman El-Menyar, Hassan Al-Thani, Ahmed Omar, Ali Barah

World Journal of Diabetes · 2026-11-15 · 17 (11)

DOI: 10.4239/wjd.124667 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Diabetic foot ischemia is a severe macrovascular complication of peripheral artery disease that critically restricts blood flow to the lower extremities, severely compromising wound healing and increasing the risk of major amputation. These high-risk patients require urgent vascular imaging and revascularization. Advanced endovascular methods are used to address the complex anatomical challenges of the ischemic diabetic foot. AIM To evaluate whether angiosome-targeted endovascular revascularization is associated with superior wound healing and limb salvage compared with non-targeted revascularization in patients with diabetic foot ischemia. METHODS A retrospective single-center cohort study was conducted. All consecutive patients with diabetic foot ischemia undergoing endovascular revascularization at Hamad General Hospital, Hamad Medical Corporation, from January 2017 to March 2025 were included. Procedure types were classified into 3 groups: targeted-only (n = 33), non-targeted-only (n = 74), and combined targeted and non-targeted (n = 35). Primary outcomes were wound healing and limb salvage. Multivariable logistic regression was used to identify independent predictors of each outcome, with non-targeted-only as the reference group. RESULTS In total, 142 patients were analyzed (mean age 65.4 ± 12.0 years; 69.7% male). Technical success was significantly lower in the targeted-only group (69.7%) than in the non-targeted-only (91.9%) and combined (91.4%) groups (P = 0.005). No significant differences were observed in wound healing (48.5% vs 51.4% vs 41.2%; P = 0.617), limb salvage (75.8% vs 76.7% vs 80.0%; P = 0.903), or major amputation rates (P = 0.888). In multivariable analysis, procedure group was not an independent predictor of either limb salvage [area under the receiver-operating characteristic curve (AUC) = 0.661; model likelihood ratio P = 0.359] or wound healing (AUC = 0.770; P = 0.0001). Independent predictors of wound healing were older age [odds ratio (OR) = 1.05, 95% confidence interval (95%CI): 1.02–1.09; P = 0.004], lower Wagner grade (OR = 0.52, 95%CI: 0.32–0.86; P = 0.010), and longer follow-up (OR = 1.41, 95%CI: 1.13–1.76; P = 0.002). CONCLUSION This study, conducted in a country with a high prevalence of diabetes mellitus, found no statistically significant association between angiosome-targeted revascularization and wound healing or limb salvage compared with non-targeted revascularization. Wound severity and follow-up duration were the dominant predictors of clinical outcomes. These findings should be interpreted in the context of the study’s retrospective design and moderate sample size. Prospective multicenter studies are warranted.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →